Influential Execs and Amazing Gut Microbia Top the News this Week

Posted on by

Craig Thompson, MD, President and CEO of MSK, makes the list of one of the Top 50 Most Influential Physician Executives and Leaders of 2016. The advances in cancer treatment and research has brought Dr. Thompson and MSK to the forefront of medical research and leadership. According to Thompson, “We’re really at a pivotal time when we can deliver on all the basic research and translational research from the past 25 years” leading to targeted treatments for individual tumors. “This isn’t science fiction. We’re doing it every day.”

Becker’s Hospital Review asked Craig to discuss their 7 questions about hospital leadership and management.

Craig Thompson was also the keynote speaker at the March 31st Lasker Lessons in Leadership Lecture in Bethesda, MD. He discussed the leadership strategies and the difference between leadership and management.

View the lecture here: Lasker Lessons in Leadership: Leadership in Medicine/Public Health Continue reading →

New Title: Thomas’ #Hematopoietic Cell Transplantation, 5th Edition

Posted on by

The MSK Library has recently added the fifth edition of Thomas’ Hematopoietic Cell Transplantation by user request!  The latest version includes the expertise of over 170 international specialists – including ones from MSK.  It also includes new chapters that look at basic science experiments in stem-cell biology, immunology, and tolerance, as well as expanded content on the benefits and challenges of transplantation.

Thomas’ Hematopoietic Cell Transplantation may be found in our eBook A-Z listing or by searching Summon.

Luminescent Chemotherapy-Filled Beads, Prostate Cancer and More…

Posted on by

The latest in the world of cancer research:

  • An innovative cancer treatment made of luminescent chemotherapy-filled beads injected into tumors through the wrist is now available for patients with inoperable and difficult-to-treat liver cancer. Here’s a video of Dr. Edward Kim from Mount Sinai Hospital performing this cancer procedure:
  • A team of scientists led by Dr. Peter S. Nelson at the Fred Hutchinson Cancer Research Center conducted a genomic analysis and found that prostate cancer metastases varied greatly between men. The study also found that a single metastasis within one individual may provide molecular information to help guide therapy. Read more on the findings in Nature Medicine.
  • Researchers at the University of Vienna have discovered why small cell lung cancer is chemoresistant. The resistance to chemo and radiation is due to the circulating tumor cells forming clusters. Completely new therapeutic approaches must therefore be developed to prevent the formation of these cancer clusters or to break them up. Read more on the discovery in Cell Adhesion and Migration.
  • Landmark research out of the University of South Wales in Australia has led to the development of a technique whereby stem cell therapies may be capable of regenerating damaged human tissue. Their findings were published in the journal Proceedings of the National Academy of Sciences.